(Q27851698)
Statements
1 reference
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. (English)
1 reference
2011
0 references
6
0 references
12
0 references
e28973
0 references
14 December 2011
1 reference